UnitedHealth Stock caught in a perfect storm, almost 50% has fallen since April – UnitedHealth Group (NYSE: UNH)

UnitedHealth Group, Inc. Ultra Has almost 50% fallen in the past month, fed by a series of negative catalysts.

Several analysts have reduced the price objectives on the shares, but one analyst has seen and reduced enough UnitedHealth on Wednesday.

What to know: Bofa Securities Analyst Kevin Fischbeck Downgraded UnitedHealth Group from Buy to Neutral and reduced the price target from $ 560 to $ 350 after the company had reached its Outlook 2025 and announced a CEO transition on Tuesday.

Read next: Trump again promises lower drug prices by ‘lowering intermediaries’ such as UnitedHealth, CFS: will it work this time?

UnitedHealth attracted his guidance after the company had noticed the Medicare Advantage trend that worsened and spread to more complex patients, such as double registrations. The analyst said that the deteriorating trend became clear after UnitedHealth had completed his claims in March and had an early look at the April claims.

Fischbeck sees the health care giant decision to draw its tax guidelines as a combination of uncertainty surrounding the prevalence of higher usage percentages and to give the incoming CEO time to adapt.

Andrew Witty Unexpected resignation taken as CEO “for personal reasons” on Tuesday and will be followed by Stephen J. Hemsley, that served as CEO of UnitedHealth from 2006 to 2017.

What else: Shareholders of UnitedHealth brought a lawsuit last week that claims that the company has misled investors by hiding the negative business effects that followed the dead of December 2024 Brian Thompson, CEO of UnitedHealthcare.

The company is still faltering of a large cyber attack on the subsidiary of changes in health care and is also confronted with an intense regulatory and legal control, including federal investigations into the Medicare invoicing practices.

The recent convergence of disappointing income, rising medical costs, lead for guidance, abrupt leadership change and regulatory challenges have undermined investor confidence and caused a dramatic revaluation of UnitedHealth shares last month.

UNH -SELEVEL -ROAD ACTION: The Shares of UnitedHealth Group ended according to the Wednesday session with 1.08% at $ 308.01, according to Petrol.

Read next:

Photo: Shutterstock